Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus | Zendy

Yoshikazu Nitta | Zendy; Nobuhiro Tahara | Zendy; Atsuko Tahara | Zendy; Akihiro Honda | Zendy; Norihiro Kodama | Zendy; Masahiro Mizoguchi | Zendy; Hayato Kaida | Zendy; Masatoshi Ishibashi | Zendy; Naofumi Hayabuchi | Zendy; Hisao Ikeda | Zendy; Shoichi Yamagishi | Zendy; Tsutomu Imaizumi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus

Author(s) -

Yoshikazu Nitta,

Nobuhiro Tahara,

Atsuko Tahara,

Akihiro Honda,

Norihiro Kodama,

Masahiro Mizoguchi,

Hayato Kaida,

Masatoshi Ishibashi,

Naofumi Hayabuchi,

Hisao Ikeda,

Shoichi Yamagishi,

Tsutomu Imaizumi

Publication year - 2013

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2013.09.004

Subject(s) - pioglitazone , glimepiride , medicine , diabetes mellitus , cardiology , coronary artery disease , type 2 diabetes , inflammation , type 2 diabetes mellitus , artery , myocardial infarction , gastroenterology , endocrinology

The aim of this study was to compare the effect of pioglitazone with glimepiride on coronary arterial inflammation with serial (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) combined with computed tomography (CT) angiography.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research